36 results
DEF 14A
VERV
Verve Therapeutics Inc
29 Apr 22
Definitive proxy
7:01am
Policy and Procedures
REPORT OF THE AUDIT COMMITTEE
CORPORATE GOVERNANCE
Director Nomination Process
Board Diversity Matrix
Director Independence
Board … -Hedging Policy
Corporate Governance Guidelines
Board Leadership Structure and Board’s Role in Risk Oversight
Communication with Our Directors
EXECUTIVE
10-K
2021 FY
EX-10.7
VERV
Verve Therapeutics Inc
14 Mar 22
Annual report
7:04am
Board of Directors
Audit Committee
Compensation Committee
Nominating and Corporate Governance Committee
The foregoing fees will be payable in arrears
S-1/A
EX-10.8
sklpz
14 Jun 21
IPO registration (amended)
6:15am
8-K
fkmwj4g
13 Jun 22
Departure of Directors or Certain Officers
4:34pm
8-K
00mq72dw340c2
9 Aug 22
Verve Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results
6:45am
S-1
EX-10.9
ewesg
28 May 21
IPO registration
4:04pm
DRS
EX-10.10
nb6akj8s8n
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.11
p5ylu4e
16 Apr 21
Draft registration statement
12:00am
S-1
zlp st1bi5
28 May 21
IPO registration
4:04pm
S-1
EX-10.10
haeehbb
28 May 21
IPO registration
4:04pm
S-1/A
0c2lsy2lgxkw9g
14 Jun 21
IPO registration (amended)
6:15am
DRS
66vxilv
16 Apr 21
Draft registration statement
12:00am
424B4
5r5ew55epiw2
17 Jun 21
Prospectus supplement with pricing info
4:50pm
8-K
EX-3.2
h66pas43mv9 dgr
21 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:06pm
S-1
EX-3.4
3nyimh1s80
28 May 21
IPO registration
4:04pm